Home / Japan / Kringle Pharma,Inc.
Kringle Pharma,Inc.
Short position disclosed on November 2, 2026.
3.70% of the capital sold short
2 disclosing funds
112 disclosures on record
Evolution of the disclosed total
0%2%4%6%8%
Aug 23Sep 11Sep 30Oct 19
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Nomura International plc | 2.68% | new | November 2, 2026 | |
| Barclays Capital Securities Ltd | 1.02% | -1.65 pt | October 30, 2026 |
Get the moves on Kringle Pharma,Inc. by mail, at most once a day.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| August 13, 2026 | Nomura International plc | 0.72% | |
| August 12, 2026 | Barclays Capital Securities Ltd | 1.37% | |
| August 12, 2026 | モルガン・スタンレーmufg証券株式会社 | 0.84% | |
| August 12, 2026 | Nomura International plc | 0.83% | |
| August 10, 2026 | Barclays Capital Securities Ltd | 1.94% | |
| August 10, 2026 | モルガン・スタンレーmufg証券株式会社 | 0.92% | |
| August 10, 2026 | Nomura International plc | 0.59% | |
| August 7, 2026 | Barclays Capital Securities Ltd | 2.27% | |
| August 6, 2026 | Barclays Capital Securities Ltd | 2.44% | |
| August 5, 2026 | Barclays Capital Securities Ltd | 2.56% | |
| August 5, 2026 | Nomura International plc | 0.68% | |
| August 4, 2026 | Barclays Capital Securities Ltd | 2.67% |
Download 112 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Japan
- FLIGHT SOLUTIONS Inc. 12.10% of the capital sold short
- Datasection Inc. 11.70% of the capital sold short
- QD Laser,Inc. 11.57% of the capital sold short
- GNI Group Ltd. 10.86% of the capital sold short
- Oncolys BioPharma Inc. 10.84% of the capital sold short
- Metaplanet Inc. 10.27% of the capital sold short
- AIMECHATEC,Ltd. 9.68% of the capital sold short
- ReYuu Japan Inc. 9.50% of the capital sold short
- Kasumigaseki Capital Co.,Ltd. 9.49% of the capital sold short
- KLab Inc. 8.85% of the capital sold short
- Astroscale Holdings Inc. 8.80% of the capital sold short
- Hutzper Inc. 8.70% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Kringle Pharma,Inc., source JPX, data as at November 2, 2026, https://www.quivad.com/action/kringle-pharma-inc?page=3